COMPASS THERAPEUTICS, INC. Operating Lease, Liability, Noncurrent
COMPASS THERAPEUTICS, INC. (CMPX) had Operating Lease, Liability, Noncurrent of $8.00 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiabilityNoncurrent · last filed 2026-08-06
- 2026-06-30: Operating Lease, Liability, Noncurrent $8.00M.
- 2026-03-31: Operating Lease, Liability, Noncurrent $8.42M.
- 2025-12-31: Operating Lease, Liability, Noncurrent $8.83M.
- 2025-09-30: Operating Lease, Liability, Noncurrent $8.83M; Operating Lease, Liability, Noncurrent as first filed $9.23M.
| Period end | Operating Lease, Liability, Noncurrent | Operating Lease, Liability, Noncurrent as first filed |
|---|---|---|
| 2026-06-30 | $8.00M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $8.42M 10-Q · filed 2026-05-05 | |
| 2025-12-31 | $8.83M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $8.83M 10-K · filed 2026-03-05 | $9.23M 10-Q · filed 2025-11-05 |
| 2025-06-30 | $9.63M 10-Q · filed 2025-08-11 | |
| 2025-03-31 | $6.27M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $6.30M 10-K · filed 2026-03-05 | |
| 2024-09-30 | $6.32M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $0.00 10-Q · filed 2024-08-12 | |
| 2024-03-31 | $189.00K 10-Q · filed 2024-05-13 | |
| 2023-12-31 | $536.00K 10-K · filed 2025-02-27 | |
| 2023-09-30 | $869.00K 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $1.20M 10-Q · filed 2023-08-03 | |
| 2023-03-31 | $1.52M 10-Q · filed 2023-05-04 | |
| 2022-12-31 | $1.84M 10-K · filed 2024-03-21 | |
| 2022-09-30 | $2.14M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $2.44M 10-Q · filed 2022-08-01 | |
| 2022-03-31 | $2.74M 10-Q · filed 2022-05-09 | |
| 2021-12-31 | $3.05M 10-K · filed 2023-03-15 | |
| 2021-09-30 | $3.33M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $3.60M 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $3.88M 10-Q · filed 2021-04-30 | |
| 2020-12-31 | $0.00 10-K · filed 2022-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |